Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cybin Inc
(NY:
CYBN
)
0.3500
+0.0040 (+1.16%)
Official Closing Price
Updated: 8:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cybin Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Is It Safe to Smoke DMT?
July 14, 2022
Via
Investor Brand Network
Online Companies Offering Mental Health Services Come Under Spotlight
July 13, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) CYB003 Phase 1/2a Clinical Trial Through Clinilabs Begins Enrollment
July 12, 2022
Via
Investor Brand Network
Clinilabs Drug Development Corporation Begins Enrollment for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder
July 12, 2022
From
Clinilabs Drug Development Corporation
Via
Business Wire
Congressional Leaders Want Studies to be Conducted on Mental Health Benefits of Psychedelics
July 11, 2022
Via
Investor Brand Network
Topics
Law Enforcement
Exposures
Legal
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Expected to Accelerate Clinical Development Path of CYB004
July 11, 2022
Via
Investor Brand Network
Cybin Completes Acquisition of Phase 1 DMT Study from Entheon Biomedical
July 11, 2022
From
Cybin Inc.
Via
Business Wire
Archaeologists Believe Hidden Andean Passageways Were Most Likely Used During Psychedelic Rituals
July 06, 2022
Via
Investor Brand Network
New Study Finds That Probiotics May Be Useful in Fight Against Depression
July 05, 2022
Via
Investor Brand Network
NJ Senate President Introduces Psilocybin Legalization Bill Containing Home-Cultivation Provision
June 29, 2022
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Adelia Announce Achievement of Milestone
June 28, 2022
Via
Investor Brand Network
Cybin Announces Additional Adelia Milestone Achievement
June 27, 2022
From
Cybin Inc.
Via
Business Wire
Why More Attention Needs to Be Paid to Paternal Mental Health
June 27, 2022
Via
Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports Initial Results from Feasibility Study
June 27, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Moving Forward with Phase 1/2a Clinical Trial after Receiving Key FDA Approval
June 27, 2022
Via
Investor Brand Network
Exposures
Product Safety
Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder
June 27, 2022
From
Cybin Inc.
Via
Business Wire
New Netflix Series to Explore the Use of Psychedelics for Mental Health
June 24, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Business Highlights, FY 2022 Results
June 22, 2022
Via
Investor Brand Network
Cybin Inc. Reports Fiscal Year 2022 Financial Results and Recent Business Highlights
June 22, 2022
From
Cybin Inc.
Via
Business Wire
Advances in Precision Medicine Boost Research on Psychedelics
June 21, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at H.C. Wainwright 1st Annual Mental Health Conference
June 16, 2022
Via
Investor Brand Network
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at H.C. Wainwright 1st Annual Mental Health Conference
June 16, 2022
Via
Investor Brand Network
Cybin to Present at the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022
June 16, 2022
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Collaborating to Progress Mission to Create Safe, Effective Therapeutics
June 15, 2022
Via
Investor Brand Network
What You Should Know About Ego Death
June 15, 2022
Via
Investor Brand Network
World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health
June 15, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a...
Via
FinancialNewsMedia
WHO Wants Climate Change Efforts to Prioritize Mental Health
June 13, 2022
Via
Investor Brand Network
Topics
Climate Change
Exposures
Climate
Four Key Takeaways from the Catalyst Summit in Canada
June 10, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Awarded Board Approval for CYB003 Phase 1/2a Clinical Trial
June 10, 2022
Via
Investor Brand Network
Cybin Receives Institutional Review Board Approval for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder
June 09, 2022
From
Cybin Inc.
Via
Business Wire
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.